Trump administration

;

Congress, don’t cut funding for HIV programs

by | May 25, 2023

Over the next few months, congressional appropriation committee leaders will have to hash out spending levels for individual government programs. President Joe Biden’s budget takes an enormous step toward meeting the nation’s goal of ending the HIV epidemic by 2030 through substantially increasing funding for HIV treatment and prevention programs. Some in Congress seem set on slashing spending. And that means domestic HIV funding could be on the chopping block. That’s a tragedy—one that could jeopardize our progress in the fight against the virus.

read more

A Trump era health care rule is breaking the law—and harming patients

by | Oct 24, 2022

Among Americans who take prescription drugs, a quarter struggle to afford their medication. For those who are in poor health or have low incomes, the portion is even higher. These days, the rising cost of everyday goods and services is forcing more people to face difficult decisions and ask themselves: How can I pay for utilities, the groceries, or the medicine that’s keeping me alive? Now imagine that someone offers you financial assistance for the express purpose of paying for your medicine—problem apparently solved. But in a cruel twist, your health insurer pockets that assistance, without counting it toward your annual deductible or out-of-pocket maximum. That’s why the HIV+Hepatitis Policy Institute, the Diabetes Leadership Council, and the Diabetes Patient Advocacy Coalition filed suit in federal court, challenging the Trump-era federal government rule that allows insurers and pharmacy benefit managers to carry out this harmful practice.

read more

We can end the HIV epidemic–but Congress must act

by | Jul 22, 2022

Imagine if Congress, with one simple action, could help end a 40-year-old epidemic, erase some of the racial inequities in healthcare, and save money in the process. That may sound too good to be true. But lawmakers can do it if they fund expanding access programs to a highly effective HIV drug in the 2023 spending bill.

read more

Congress: Fund PrEP to end the HIV epidemic

by | Jun 22, 2022

As the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies considers this week what programs to fund in the 2023 budget, many public health concerns will demand their attention. One funding decision that would aim to end HIV — and that goal can be achieved — would also provide long-term benefits for the entire health care system. HIV continues to infect thousands of Americans each year, many of them gay men, even though an effective prevention tool known as pre-exposure prophylaxis (PrEP) is available. PrEP, which lowers the risk of contracting HIV by 99%, was first approved by the FDA in 2012 as a daily pill and is now available in a superior form as an every-other-month injection.

read more

Search

Pin It on Pinterest